VBI Vaccines Inc expected to post a loss of 7  cents a share - Earnings Preview

VBI Vaccines

25/02/2022 16:17

* VBI Vaccines Inc  VBIV.OQ   VBIV.O  is expected to show a
fall
in quarterly revenue when it reports  results on February 28
(estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 16.3% decrease in revenue to $137.33 thousand from $164
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for VBI Vaccines Inc is
for a
loss of 7 cents per share. For the same quarter last year, the
company reported a loss of 6 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $8​, about 81.3% above​ its last closing price of $1.50. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.07       -0.07      -0.06     Beat    14.3
 Jun. 30 2021  -0.06       -0.06      -0.07     Missed  -23.5
 Mar. 31 2021  -0.06       -0.06      -0.07     Missed  -16.7​
 Dec. 31 2020  -0.06       -0.06      -0.06     Met     -3.4
 ​​Sep.        -0.04       -0.04      -0.06     Missed  -33.3
 30 2020                                                
 Jun. 30 2020  -0.04       -0.04      -0.04     Met     0​
 Mar. 31 2020  -0.06       -0.06      -0.05     Beat    20
 Dec. 31 2019  -0.05       -0.06      -0.02     Beat    65.2
 This summary was machine generated February 25 at 16:16 GMT. 
All figures in US dollars  unless otherwise stated